Scotts Miracle‑Gro reports Q4 loss but beats EPS guidance and raises FY2027 outlook

Scotts Miracle‑Gro announced its fiscal 2026 fourth‑quarter results on November 4, 2026. The company posted a non‑GAAP loss of $2.16 per share, better than the $2.21 estimate, on Q4 revenue of $302.9 million. Full‑year adjusted earnings per share rose 18% to $4.48 and net sales grew 1% to $3.29 billion. Management guided FY2027 net‑sales growth of 2%‑4% and adjusted EPS of $4.70‑$4.90, while targeting a leverage ratio of 3.0‑3.5× by fiscal 2029.

The company expects FY2027 adjusted EPS of $4.70‑$4.90, above the consensus of $4.41, which could support a higher valuation. The leverage target of 3.0‑3.5× by FY2029 signals continued balance‑sheet de‑leveraging.

  • 1Q4 non‑GAAP loss was $2.16 per share, beating estimates by $0.05.
  • 2Q4 revenue was $302.9 million.
  • 3Full‑year adjusted EPS was $4.48, an 18% increase year‑over‑year.
  • 4Full‑year net sales were $3.29 billion, a 1% increase year‑over‑year.
  • 5Free cash flow for FY2026 was $278.4 million.
  • 6Net leverage at fiscal year‑end was 3.89×, improving 0.21× versus the prior year.

Sources